KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Cardinal Health (CAH) EBIAT (2016 - 2025)

Cardinal Health (CAH) has disclosed EBIAT for 17 consecutive years, with $467.0 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 16.46% to $467.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, up 27.18% year-over-year, with the annual reading at $1.6 billion for FY2025, 83.22% up from the prior year.
  • EBIAT hit $467.0 million in Q4 2025 for Cardinal Health, up from $454.0 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $506.0 million in Q1 2025 to a low of -$1.4 billion in Q1 2022.
  • Historically, EBIAT has averaged $151.1 million across 5 years, with a median of $235.5 million in 2024.
  • Biggest five-year swings in EBIAT: tumbled 1268.91% in 2022 and later soared 3766.67% in 2024.
  • Year by year, EBIAT stood at $49.0 million in 2021, then plummeted by 257.14% to -$77.0 million in 2022, then skyrocketed by 577.92% to $368.0 million in 2023, then grew by 8.97% to $401.0 million in 2024, then rose by 16.46% to $467.0 million in 2025.
  • Business Quant data shows EBIAT for CAH at $467.0 million in Q4 2025, $454.0 million in Q3 2025, and $239.0 million in Q2 2025.